![Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7007e1_DoubleMasksEfficacy_IMAGE_10Feb21_1200x627.jpg?_=60718)
Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 | MMWR
![Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 | MMWR Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7044e1_NaturalvsVaccineImmunity_IMAGE_29Oct21_1200x675.jpg)
Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 | MMWR
![Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 | MMWR Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm71333e1_SevereIllnessGuidance_IMAGE_11Aug2022_Overview_1200x675.jpg?_=54939)
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 | MMWR
![COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7104e2_IncidenceDeathRatesOmicron_IMAGE_21Jan22_1200x627.jpg?_=64029)
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
![Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections](https://www.news-medical.net/images/news/ImageForNews_733968_16712074067993224.jpg)
Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections
![COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis](https://medicine.wustl.edu/wp-content/uploads/Long-Covid-Brain-opening-image-1.jpg)
COVID-19 infections increase risk of long-term brain problems – Washington University School of Medicine in St. Louis
![Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study - The Lancet Infectious Diseases Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/aa3362f7-3b00-4d5d-8f7d-fb86c3d823e0/gr1.jpg)